In this article, we will take a look at the Top 5 Boring Stocks That Make Money. For deeper analysis and discussion, read Top 10 Boring Stocks That Make Money.
5. Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) is one of the most boring stocks that make money.
TheFly reported on March 12 that Wells Fargo increased its price target for RYTM to $143 from $136 while keeping an Overweight rating on the stock. The update reflects slightly higher revenue projections and greater confidence in the launch of IMCIVREE for hypothalamic obesity. Discussions with physicians treating early patient populations post-approval reinforced the firm’s view of the therapy’s peak market potential.
Separately, on March 1, Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) released new 52-week results from its global Phase 3 TRANSCEND trial evaluating setmelanotide in patients with acquired hypothalamic obesity (HO). The updated dataset included 12 patients from a Japanese cohort and 10 additional participants beyond the original 120-patient pivotal cohort. Results showed a 16.4% mean reduction in BMI for treated patients compared with a 2.4% increase in the placebo group at 52 weeks, with a placebo-adjusted difference of 18.8%. Among patients aged 12 and older, weekly average hunger scores declined by 2.5 points in the setmelanotide group versus 1.3 points in the placebo group.
RYTM emphasized that these findings reinforce the therapy’s potential as the first treatment addressing the hyperphagia, reduced energy expenditure, and rapid weight gain associated with acquired HO, supporting ongoing regulatory discussions and submission plans in the U.S., Europe, and Japan.
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) is a biopharmaceutical company developing therapies for rare genetic disorders of obesity by targeting appetite regulation pathways.
4. American Airlines Group Inc. (NASDAQ:AAL)
American Airlines Group Inc. (NASDAQ:AAL) is one of the most boring stocks on this list.
TheFly reported on March 12 that Evercore ISI revised its price target for AAL to $14 from $17 while maintaining an In-Line rating. The update reflects adjustments to airline coverage estimates, incorporating higher projected fuel costs that were partially offset by slightly stronger revenue expectations.
In a similar vein, Jefferies reduced its price target for American Airlines Group Inc. (NASDAQ:AAL) from $15 to $12 on the same day, but it kept the stock’s Hold rating. In comparison to the January average used when U.S. carriers released recommendations, the cost of jet fuel has risen by around 50%, which is reflected in the change.
The firm updated its airline estimates, raising Q1 fuel cost projections by about 14% and Q2 by roughly 30%. Despite these increases, the analysis assumes fuel prices will trend back toward pre-conflict levels in the second half of the year due to market volatility. These adjustments highlight the sensitivity of airline financial performance to energy costs while keeping the company’s outlook cautiously balanced in light of revenue trends and operational factors.
American Airlines Group Inc. (NASDAQ:AAL) is a major U.S. airline providing passenger and cargo air transportation, operating a global network of domestic and international flights.
3. Dianthus Therapeutics, Inc. (NASDAQ:DNTH)
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) is among the most boring stocks.
TheFly reported on March 12 that Wedbush raised its price target on DNTH to $103 from $80 while reiterating an Outperform rating. The firm updated its estimates following the company’s recent secondary offering, factoring in the $675 million capital raise and assuming full exercise of the overallotment option. While awaiting more detailed CAPTIVATE data, Wedbush expects Claseprubart could show stronger response rates and more convenient dosing than riliprubart, which may support its competitive position in CIDP.
Additionally, on March 12, Dianthus Therapeutics, Inc. (NASDAQ:DNTH) announced that it completed its previously announced upsized underwritten public offering, raising about $719 million in gross proceeds before fees and expenses. The transaction included 8.47 million common shares, reflecting the full exercise of the underwriters’ option for additional shares, along with pre-funded warrants issued to certain investors in place of common stock.
DNTH said the capital will support its clinical and preclinical pipeline, preparations for potential commercialization, and general corporate needs. The financing meaningfully strengthens the company’s balance sheet as it advances next-generation treatments for severe autoimmune diseases and expands its development efforts across key programs.
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) is a clinical-stage biotech company developing antibody therapies for severe autoimmune and inflammatory diseases.
2. Apollo Global Management, Inc. (NYSE:APO)
Apollo Global Management, Inc. (NYSE:APO) is one of the most boring stocks.
TheFly reported on March 12 that Atlético de Madrid confirmed that Apollo Sports Capital (ASC), a sports-focused investment affiliate of APO, finalized its previously announced investment and became the club’s controlling shareholder. Following the deal, Quantum Pacific Group remains the second-largest investor, while Miguel Ángel Gil, Enrique Cerezo, and Ares funds continue to hold ownership stakes.
Miguel Ángel Gil and Enrique Cerezo will stay in their current leadership roles as CEO and Chairman. The board also approved up to an additional €100 million in equity and strategic capital to help fund future initiatives, including team development and major infrastructure projects tied to Ciudad del Deporte.
Earlier in the week, on March 10, Apollo Global Management, Inc. (NYSE:APO) said it is preparing to launch its first Long-Term Asset Fund in the U.K., the CG Apollo Global Diversified Credit LTAF, after receiving authorization from the Financial Conduct Authority. The fund is structured as a semi-liquid, multi-sector private credit strategy designed for U.K. defined contribution pension plans.
It will provide access to a broadly diversified global credit portfolio with a primary focus on private credit, including private investment-grade debt, large-cap corporate lending, and asset-backed finance. The launch marks a key step in Apollo’s push to expand institutional-style private market retirement solutions for modern pension savers.
Apollo Global Management, Inc. (NYSE:APO) is an alternative asset manager providing private equity, credit, and retirement services solutions to institutional and individual investors.
1. Robinhood Markets, Inc. (NASDAQ:HOOD)
Robinhood Markets, Inc. (NASDAQ:HOOD) is one of the most boring stocks.
TheFly reported on March 13 that Mizuho reduced its price target on HOOD to $110 from $135 while maintaining an Outperform rating. The firm pointed to HOOD’s February update, which showed consistent customer growth alongside uneven trading trends. Equity and options activity weakened from the prior period, while crypto trading remained relatively strong. Mizuho also lowered its fiscal 2026 revenue forecast by 2%, citing a softer overall trading environment driven by global uncertainty and weaker cryptocurrency prices. In addition, the firm trimmed the stock’s valuation multiple to reflect the more subdued retail trading backdrop.
Separately, on March 6, Robinhood Ventures Fund I (NYSE:RVI), the company’s closed-end fund that intends to invest primarily in private companies operating at the frontiers of their industries, priced its initial public offering of 12,615,608 common shares at $25.00 each, establishing an initial fund size of approximately $658.4 million before fees and expenses. The total could increase to as much as $705.7 million if the underwriter fully exercises its option to purchase additional shares.
The fund is structured as a closed-end vehicle designed to give retail investors access to a concentrated portfolio of private companies. Its shares were expected to begin trading on the New York Stock Exchange on March 6 under the ticker RVI, with the offering scheduled to close on March 9, subject to customary conditions.
Robinhood Markets, Inc. (NASDAQ:HOOD) is a financial services platform offering commission-free trading in stocks, ETFs, options, futures, and cryptocurrencies, along with retirement and cash management products.
While we acknowledge the potential of HOOD to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than HOOD and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 40 Most Popular Stocks Among Hedge Funds Heading Into 2026 and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
